Sp800
INTRAOPERATIVE PANCREATOSCOPY Q&A
Date
May 20, 2024
Presenters
Tracks
Related Products
EXERCISE STIMULATES ANTITUMORAL IMMUNITY IN PANCREATIC DUCTAL ADENOCARCINOMA
The majority of pancreatic ductal adenocarcinoma (PDAC) patients are metastatic at presentation with limited treatment options and a poor overall 5-year survival of 3%. The liver is the predominant site of distant metastasis in PDAC…
INTRAOPERATIVE PANCREATOSCOPY DURING PANCREATECTOMY IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM INVOLVING THE MAIN PANCREATIC DUCT: PROSPECTIVE MULTICENTER STUDY
BACKGROUND & AIMS: Minimal prospective data are available on intraoperative pancreatoscopy (IOP) for the diagnostic work-up of intraductal papillary mucinous neoplasia (IPMN)…
UTILIZATION OF NEOADJUVANT THERAPY IN ELDERLY PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: AN NCDB STUDY
Management of patients with margin negative, T1-T3, N0 (stage IB–IIIA), resected gallbladder cancer (GBC) remains poorly defined. Current guidelines consider observation, chemotherapy (CT), and chemoradiation (CRT) as options…
